Study will evaluate first-in class treatment in six European countries Downloa ...
Learn MoreForbion & Seroba co-led funding, forming international consortium of M ...
Learn MoreL’étude montre que le modulateur allostérique positif mGluR4 est sûr et bie ...
Learn MoreFirst clinical trial with an mGluR4 positive allosteric modulator, a first-in-cl ...
Learn MoreSwiss based startup attracts venture funding from leading European VC firms ...
Learn MoreJanuary 22, 2013. Prexton Therapeutics will develop novel mGluR4 PAM seri ...
Learn MoreJuly 30, 2012. Merck Serono announces the creation of the first spin-off company ...
Learn More